Breaking News
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
January 18, 2018 - FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
January 18, 2018 - Oncologists Dish on Top Issues for 2018
January 18, 2018 - Researchers identify new potential drug target for Huntington’s disease
January 18, 2018 - Metrohm USA welcomes employees to new headquarters in Florida
January 18, 2018 - Human waste remains main source of fecal pollution in the river Danube
January 18, 2018 - Expert discusses how to stay healthy during flu season
January 18, 2018 - New biomaterials-based system improves T-cell production
January 18, 2018 - Novel gene expression analysis technique can accurately and quickly measure RNA
January 18, 2018 - Grandparents Help Shape Kids’ Views on Aging
January 18, 2018 - Absolutely Zero Stent Thrombosis at 5 Years With Bioabsorbable MiStent
January 18, 2018 - Safe Sleep for Babies | VitalSigns
January 18, 2018 - Pfizer to launch own little white pill
January 18, 2018 - Aged garlic extract may help obese people fight against inflammation, study shows
January 18, 2018 - Patients with monoclonal gammopathy at risk of developing cancer even after 30 years
January 18, 2018 - Researchers reveal potential of multivalent antibodies for HIV prevention, treatment and cure
January 18, 2018 - Dying cancer patients receiving assisted hydration live longer
January 18, 2018 - Potential male birth control pill could be developed from arrow poison
January 18, 2018 - Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations
January 18, 2018 - Genes involved in spinal cord repair of lamprey also present in mammals, study reveals
January 18, 2018 - Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases
January 18, 2018 - The State of the Drug Discovery Nation Unveiled as New Report Provides Vital Insights for the Development of New Medicines
January 18, 2018 - Dutch Study Links Implants to Increased Breast-ALCL Risk
January 18, 2018 - Five addiction experts weigh in on future of opioid crisis. Their forecast: grim
January 18, 2018 - EXD2 enzyme facilitates protein production in mitochondria
January 18, 2018 - Kessler Foundation wins $735,000 grant for training rehabilitation researchers
January 18, 2018 - Researchers find new way to halt growth of breast cancer cells
January 18, 2018 - Cantex Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Treatment of Acute Myeloid Leukemia
January 18, 2018 - Civilians Now Getting Flu-Like Illness Afflicting Troops
January 18, 2018 - Discovery brings stem cell therapy for eye disease closer to the clinic
January 18, 2018 - Guts of surfers more likely to be colonized by antibiotic-resistant bacteria, study reveals
January 18, 2018 - Bacteria linked to periodontitis may play role in onset of cancer
January 18, 2018 - Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
January 18, 2018 - Early Menarche, Menopause Tied to Higher CVD Risk
January 18, 2018 - Pioneering new technique could boost understanding of causes of heart disease
January 18, 2018 - New brain imaging techniques show how infants’ brains process ‘touch’
January 18, 2018 - GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
January 18, 2018 - Blood Markers Point to Maladaptive LV Remodeling
January 18, 2018 - Effect of gut bacteria on specific immune cells underlies persistent liver inflammation
January 18, 2018 - Study reveals new diabetes gene in families with rare blood sugar conditions
January 18, 2018 - Fewer Hospitals Closed After Obamacare Expanded Medicaid
January 18, 2018 - At-Home Breath Training Improves Asthma Quality of Life
January 18, 2018 - Obesity can add five weeks of asthma symptoms per year in preschoolers
January 18, 2018 - Neuronal loss is very limited in Alzheimer’s disease, shows new study
January 18, 2018 - A new strategy proposed for drug discovery
January 17, 2018 - Lactation May Lower T2D Risk in Younger Women
January 17, 2018 - New Atopic Dermatitis Yardstick provides practical guidance and management insights
January 17, 2018 - New biodegradable pressure sensor could help monitor serious health conditions
January 17, 2018 - HSS orders Sectra’s 3D pre-operative planning solution for improving patient outcomes
January 17, 2018 - Study identifies six new genes regions associated with diabetes
January 17, 2018 - Women do not receive timely diagnosis for heart disease
January 17, 2018 - AbbVie’s Upadacitinib Shows Positive Results as Monotherapy in Phase 3 Rheumatoid Arthritis Study, Meeting All Primary and Key Secondary Endpoints
January 17, 2018 - Should President Trump’s Physical Include a Cognitive Screen?
January 17, 2018 - Could gene therapy someday eliminate HIV?
January 17, 2018 - Researchers identify new anti-inflammatory drug target
January 17, 2018 - Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers
January 17, 2018 - Trunk Imaging Tied to Higher Nephrectomy Risk
January 17, 2018 - Campaigners incensed at failings in Africa AIDS war
January 17, 2018 - Research opens door to development of new treatment for type 2 diabetes
January 17, 2018 - Uniqsis’ novel reactor system for continuous flow synthesis
January 17, 2018 - Bariatric surgery extends lifespan in obese patients, shows study
January 17, 2018 - Genevac offers miVac DNA for efficient concentration of nucleic acids
January 17, 2018 - Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease
January 17, 2018 - Systematic bright light exposure can improve sleep in people treated for cancer
January 17, 2018 - Ewww Moments in the ER: That’s Improbable!
January 17, 2018 - Scientists discover possible cause of colonial-era epidemic in Mexico
January 17, 2018 - Methods from optogenetics, machine learning should help improve treatment options for stroke patients
Penn Medicine to conduct Northeast’s first clinical trial of uterine transplants

Penn Medicine to conduct Northeast’s first clinical trial of uterine transplants

image_pdfDownload PDFimage_print

Penn Medicine will conduct the Northeast’s first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) – an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States – with a new path to parenthood. A woman with UFI cannot carry a pregnancy either because she was born without a uterus, has had the organ surgically removed, or has a uterus that does not function properly. The Uterine Transplantation for Uterine Factor Infertility (UNTIL) trial is the third of its kind in the United States.

To date, more than 30 uterine transplants have been completed across the world including in Brazil, China, the Czech Republic, Germany, Sweden, India, Saudi Arabia, Turkey, and at two clinics in the United States. Though the procedure is still experimental, a team in Sweden who completed the world’s first uterine transplant has successfully delivered eight babies from women who received a uterus from a friend or family member.

“While there are still many unknowns about uterine transplantation, we know this approach has the potential to give women with UFI a real opportunity to carry and deliver a child,” said Kate O’Neill, MD, MTR, an assistant professor of Obstetrics and Gynecology in the Perelman School of Medicine at the University of Pennsylvania, and co-principal investigator on the UNTIL trial. “The strength of Penn’s research program and exceptional quality of care, particularly in transplant and women’s health, makes us uniquely positioned to be a leading clinical research program for uterine transplants in the United States, and to continue to advance this emerging field.”

Uterine transplantation is a complex procedure that involves both surgical and medical components. Following an extensive evaluation, participants in the UNTIL trial will be followed for several years by a multidisciplinary team of specialists with expertise in transplant, obstetrics & gynecology, clinical trials, bioethics, nursing, social work, psychology, pathology, and infectious diseases. More than 35 providers will be involved in each participant’s care over the course of a five- to 10-year period.

Participants in the trial will move through three phases:

  • Pre-transplant: After screening and enrollment, participants will undergo in vitro fertilization (IVF), during which their eggs are harvested and fertilized to create embryos that are then cryopreserved for transfer into the uterus following transplantation.
  • Transplant: Participants will go through a standard transplant evaluation before they are listed with the United Network for Organ Sharing (UNOS). After transplant surgery, participants will begin a regimen of standard immunosuppressant medications – similar to those taken by solid organ transplant recipients – to keep the body from rejecting the transplanted organ. Participants are then closely monitored for one year after the transplant to evaluate their psychological, social, and physical well-being.
  • Post-transplant: Once the participant heals, and the uterus is healthy and functioning, a single embryo will be placed into the uterus. If they become pregnant, participants will be monitored closely by a team of obstetricians, specializing in high-risk pregnancies. Babies will be delivered via cesarean section at approximately 37 to 39 weeks (or earlier if needed for the health of the mother and/or baby).

“In most cases, the absence of a uterus also means these women likely do not have a ‘normal’ vaginal canal, making it risky, or impossible, for them to have a vaginal delivery. However, our team of experts is taking every precaution to ensure the health and safety of both our mothers and babies,” said Eileen Wang, MD, an associate professor of Obstetrics and Gynecology and Maternal Fetal Medicine, and co-principal investigator on the UNTIL trial. “Though there isn’t enough research on uterine transplants in particular, we have data and experience caring for mothers with other organ transplants, including kidney and heart, often with good outcomes for mothers with healthy children under careful surveillance. With appropriate management and medication, we do not see increased congenital abnormalities in these fetuses.”

Once a recipient has delivered up to two healthy babies, the transplanted uterus will be removed via hysterectomy, allowing the participant to discontinue use of anti-rejection medications.

The UNTIL trial plans to transplant organs from deceased donors between the ages of 21 and 40, who have successfully delivered healthy children.

“We have engaged our local organ procurement organization (OPO), the Gift of Life Donor Program (GLDP), to begin collaborating on this innovative project,” said Paige Porrett, MD, PhD, an assistant professor of Transplant Surgery, and co-principal investigator on the UNTIL trial. “We look forward to building on the strength of our established partnership with GLDP to provide donor families an additional opportunity to improve others’ lives through transplantation.”

The UNTIL trial is a joint effort between Penn Medicine’s department of Obstetrics & Gynecology and the Penn Transplant Institute. The procedure is part of the highly specialized vascularized composite allotransplantation (VCA) field, which in recent years has allowed for the development of advanced procedures that require the transplantation of multiple tissues such as muscle, bone, nerve, and skin, as a functional unit, such as hands and the face. In addition to the standard research study oversight, this study will be conducted in accordance with transplant center and OPO regulatory requirements, including highly specific authorization and screening requirements governing VCA transplantation and donation.

During the past year, the Penn team has been practicing the surgical procedure in Penn’s Human Tissue Lab in an effort to hone their skills, perfect the surgical technique, and develop detailed plans for coordination across the entire team. Transplant rehearsals will continue in the coming months as the team prepares for the first trial participants.

“The results of the VCA surgeries performed here at Penn have been very promising, and give us the foundation necessary to continue moving ahead with advancements in the field,” Porrett said. “Leadership from OB-GYN and transplant have been incredibly supportive of our mission to help more women and their families realize their dreams of becoming pregnant, carrying healthy babies, and becoming parents.”

Source:

https://www.pennmedicine.org/news/news-releases/2017/november/penn-medicine-launches-first-clinical-trial-for-uterine-transplant-in-the-northeast

Tagged with:

About author

Related Articles